Taking tamoxifen to prevent breast cancer can save lives and cut medical costsMarch 14th, 2011 - 4:42 pm ICT by ANI
Washington, Mar 14 (ANI): A new research has revealed that tamoxifen, taken by certain women as a preventive measure against breast cancer, saves lives and money.
The study’s results suggest that the benefits of tamoxifen to prevent cancer can sufficiently compensate for its side effects in post-menopausal women under age 55 years who have an increased risk of developing breast cancer.
Research has shown that tamoxifen can protect against breast cancer for years after treatment ends, but identifying the group of women who can most benefit from the drug as a cancer preventive agent, without experiencing serious side effects, is a challenge. Side effects of the drug can include pulmonary embolism, endometrial cancer, deep vein thrombosis, and cataracts, as well as hot flashes and early menopause.
To investigate those women who would benefit the most from taking tamoxifen as a cancer preventive drug, Peter Alperin, MD, of Archimedes Inc. in San Francisco, and his colleagues used a mathematical model to simulate a post-menopausal population under age 55 years in a virtual clinical trial comparing tamoxifen treatment with no treatment.
The investigators modeled tamoxifen therapy based on an analysis of four randomized, placebo-controlled cancer prevention trials, and they assessed the effects that tamoxifen would have on women’s breast cancer risk for 10 years following the end of treatment.
Cancer incidences and survival information were taken from the Surveillance Epidemiology and End Results cancer registry, while factors such as non-cancer disease incidences, quality of life, and costs were taken from the medical literature.
The researchers found that in post-menopausal women ages 55 years and younger with a 5-year risk of developing breast cancer of 1.66 percent or greater, the benefits of tamoxifen are maximized while its side effects are minimized.
“In this group of women, using tamoxifen to prevent breast cancer saves lives and has a low frequency of side effects,” said Dr. Alperin. He added that it also saves medical costs.
The study has been published early online in CANCER, a peer-reviewed journal of the American Cancer Society. (ANI)
- Postmenopausal smoking boosts sex hormone levels - Sep 01, 2011
- Preventive use of breast cancer drugs urged - Mar 28, 2011
- Gene mutation ups blood-clot risk in women taking breast cancer treatment - Jun 17, 2010
- 3 drugs found to reduce breast cancer risk, have distinct side effects - Sep 16, 2009
- Drug counters bone-damaging effects of breast cancer medication - Oct 10, 2011
- Breast cancer survivors are at higher risk for hip fractures - Feb 03, 2011
- 10 tips to steer clear of breast cancer - Oct 03, 2010
- Breast cancer survivors 'more likely to fall' - Mar 05, 2011
- Breast cancer treatment lowers sex drive - Mar 13, 2011
- High-risk women hesitant to take breast cancer preventive drug - Dec 03, 2009
- Diabetes drug may provide protection against endometrial cancer - Apr 06, 2011
- Soya beans could help to fight cancer - Jan 14, 2011
- High soy intake reduces risk of breast cancer - Jun 15, 2010
- Smoking linked to increased risk of breast cancer - Jan 25, 2011
- Cough syrup may help predict breast cancer drug's effectiveness - Nov 20, 2010
Tags: alperin, archimedes, breast cancer, breast cancer research, breast cancer risk, cancer disease, cancer prevention trials, cancer registry, deep vein thrombosis, early menopause, group of women, incidences, mathematical model, medical costs, medical literature, menopausal women, preventive agent, preventive measure, tamoxifen, women ages